Literature DB >> 8829806

Protease activity appeared after trypsin treatment of the purified vitellogenin from eel Anguilla japonica.

M Komatsu1, W Matsumoto, S Hayashi.   

Abstract

Density gradient ultracentrifugation and anion-exchange chromatography combination were effective for the purification of the eel vitellogenin from the plasma of estradiol-treated eels. The vitellogenin was very high density glycolipoprotein (P = 1.27 g/ml) and its apolipoprotein was M(r) 196 k in both reduced and non-reduced conditions by SDS-PAGE. The major lipid component was phospholipid. The N-terminal amino-acid sequence of the vitellogenin was as follows: (Ac)Thr-Pro-Ala-Leu/Ala-Asp-Tyr. Amino-acid composition of the eel vitellogenin was similar to those of other teleosts. The protease activity appeared in the trypsinized vitellogenin, but was not detected in the purified vitellogenin. The protease was separated from the used trypsin and the other cleaved vitellogenin by a dextran sulfate cellulose column. The molecular weight of the protease was determined by zymogram using SDS-polyacrylamide gel containing casein and was 50 k. It was concluded that the eel vitellogenin possesses the protease activity as a latent form.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8829806     DOI: 10.1016/0305-0491(95)02079-9

Source DB:  PubMed          Journal:  Comp Biochem Physiol B Biochem Mol Biol        ISSN: 1096-4959            Impact factor:   2.231


  2 in total

1.  Fluorescence Quenching Determination of Uranium (VI) Binding Properties by Two Functional Proteins: Acetylcholinesterase (AChE) and Vitellogenin (Vtg).

Authors:  Frédéric Coppin; Jérôme Michon; Cédric Garnier; Sandrine Frelon
Journal:  J Fluoresc       Date:  2015-03-13       Impact factor: 2.217

2.  The molecular and structural characterization of two vitellogenins from the free-living nematode Oscheius tipulae.

Authors:  Daniela P Almenara; Joselene P de Moura; Cristiane P Scarabotto; Russolina B Zingali; Carlos E Winter
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.